WallStreetZenWallStreetZen

NASDAQ: ORIC
Oric Pharmaceuticals Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

ORIC earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$100.7M
Current Profit Margin
0%

ORIC Return on Equity

Current Company
-42.7%
Current Industry
-63.5%
Current Market
188%
ORIC's Return on Equity (-42.7%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ORIC announces earnings.

ORIC Return on Assets

Current Company
-38.6%
Current Industry
2.9%
ORIC is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ORIC Return on Capital Employed

Current Company
-43.49%
Current Industry
19.5%
ORIC's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ORIC vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ORIC$0.00-$99.67M-$100.70MN/AN/A
GHRS$0.00-$34.55M-$35.59MN/AN/A
PHAT$682.00k-$159.05M-$201.59MN/AN/A
LYEL$130.00k-$214.38M-$234.63M-33.30%N/A
IGMS$2.13M-$232.05M-$246.42M+99.25%N/A
View Top Biotech Stocks

ORIC earnings dates

Next earnings date
Jun 12, 2024

Oric Pharmaceuticals Earnings & Revenue FAQ

What were ORIC's earnings last quarter?

On Invalid Date, Oric Pharmaceuticals (NASDAQ: ORIC) reported Q4 2023 earnings per share (EPS) of -$0.50, up 3.85% year over year. Total Oric Pharmaceuticals earnings for the quarter were -$28.33 million. In the same quarter last year, Oric Pharmaceuticals's earnings per share (EPS) was -$0.52.

If you're new to stock investing, here's how to buy Oric Pharmaceuticals stock.

What was ORIC's earnings growth in the past year?

As of Q2 2024, Oric Pharmaceuticals's earnings has grown year over year. Oric Pharmaceuticals's earnings in the past year totalled -$100.70 million.

What is ORIC's earnings date?

Oric Pharmaceuticals's earnings date is Invalid Date. Add ORIC to your watchlist to be reminded of ORIC's next earnings announcement.

What was ORIC's revenue last quarter?

On Invalid Date, Oric Pharmaceuticals (NASDAQ: ORIC) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Oric Pharmaceuticals's revenue was $0.00.

What was ORIC's revenue growth in the past year?

As of Q2 2024, Oric Pharmaceuticals's revenue has grown null year over year. Oric Pharmaceuticals's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.